Sunshine Biopharma Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Sunshine Biopharma Inc. on May 8, 2024, covering the event date of May 7, 2024. The Company is incorporated in Colorado and trades on The Nasdaq Stock Market LLC under the symbols SBFM (Common Stock) and SBFMW (Warrants).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance change regarding the independent registered public accounting firm.
Material Changes
Effective May 7, 2024, the Company retained Bush & Associates CPA LLC as its new independent registered public accounting firm. This decision was approved by the unanimous consent of the Board of Directors. The filing confirms that during the two most recent fiscal years and the subsequent interim period, the Company did not consult with Bush & Associates regarding accounting principles, audit opinions, or other matters required under Regulation S-K Item 304(a)(2)(i) or (ii).
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the change in auditors.
Investor Verification Checklist
- Verify the effective date of the engagement with Bush & Associates CPA LLC (May 7, 2024).
- Confirm the unanimous Board of Directors approval for the auditor change.
- Review the Company's prior filings to identify the name of the outgoing independent registered public accounting firm.
- Check for any subsequent filings that may detail the reasons for the auditor change, as this 8-K does not explicitly state the rationale.